All Stories

  1. ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy

    Article • Cells, January 2025, MDPI AG

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  2. CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy

    Article • International Journal of Molecular Sciences, October 2023, MDPI AG

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  3. Thymoquinone Attenuates Retinal Expression of Mediators and Markers of Neurodegeneration in a Diabetic Animal Model

    Article • Current Molecular Pharmacologye, April 2023, Bentham Science Publishers

    DR AJAZ AHMAD, Mr MOHAMMAD MAIRAJ SIDDIQUEI

  4. Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy

    Article • Molecules, September 2022, MDPI AG

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  5. Proprotein convertase furin is a driver and potential therapeutic target in proliferative diabetic retinopathy

    Article • Clinical and Experimental Ophthalmology, April 2022, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  6. Tissue Inhibitor of Metalloproteinase-3 Ameliorates Diabetes-Induced Retinal Inflammation

    Article • Frontiers in Physiology, January 2022, Frontiers

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  7. The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors

    Article • Cancers, October 2021, MDPI AG

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  8. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy

    Article • Investigative Ophthalmology & Visual Science, July 2021, Association for Research in Vision and Ophthalmology (ARVO)

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  9. Apocynin ameliorates NADPH oxidase 4 (NOX4) induced oxidative damage in the hypoxic human retinal Müller cells and diabetic rat retina

    Article • Molecular and Cellular Biochemistry, January 2021, Springer Science + Business Media

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  10. Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy

    Article • Frontiers in Immunology, January 2021, Frontiers

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  11. The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy

    Article • Frontiers in Immunology, December 2019, Frontiers

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  12. Interleukin-11 Overexpression and M2 Macrophage Density are Associated with Angiogenic Activity in Proliferative Diabetic Retinopathy

    Article • Ocular Immunology and Inflammation, August 2019, Taylor & Francis

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  13. Galectin‐1 studies in proliferative diabetic retinopathy

    Article • Acta Ophthalmologica, July 2019, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  14. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy

    Article • Current Eye Research, June 2019, Taylor & Francis

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  15. The Poly(ADP-Ribose)Polymerase-1 Inhibitor 1,5-Isoquinolinediol Attenuate Diabetes-Induced NADPH Oxidase-Derived Oxidative Stress in Retina

    Article • Journal of Ocular Pharmacology and Therapeutics, September 2018, Mary Ann Liebert Inc

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  16. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy

    Article • Acta Ophthalmologica, November 2017, Wiley

    Dr Ahmed Mousa, Mr MOHAMMAD MAIRAJ SIDDIQUEI

  17. Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy

    Article • Ocular Immunology and Inflammation, September 2017, Taylor & Francis

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  18. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy

    Article • Investigative Ophthalmology & Visual Science, June 2017, Association for Research in Vision and Ophthalmology (ARVO)

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  19. Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy

    Article • Acta Ophthalmologica, April 2017, Wiley

    Dr Ahmed Mousa, Mr MOHAMMAD MAIRAJ SIDDIQUEI

  20. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy

    Article • Acta Ophthalmologica, November 2016, Wiley

    Dr Ahmed Mousa, Mr MOHAMMAD MAIRAJ SIDDIQUEI

  21. Myeloid-Related Protein-14/MRP-14/S100A9/Calgranulin B is Associated with Inflammation in Proliferative Diabetic Retinopathy

    Article • Ocular Immunology and Inflammation, November 2016, Taylor & Francis

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  22. High-Mobility Group Box-1 Protein Mediates the Regulation of Signal Transducer and Activator of Transcription-3 in the Diabetic Retina and in Human Retinal Müller Cells

    Article • Ophthalmic Research, August 2016, Karger Publishers

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  23. Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy

    Article • Current Eye Research, June 2016, Taylor & Francis

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  24. Upregulated Expression of Heparanase in the Vitreous of Patients With Proliferative Diabetic Retinopathy Originates From Activated Endothelial Cells and Leukocytes

    Article • Investigative Ophthalmology & Visual Science, December 2015, Association for Research in Vision and Ophthalmology (ARVO)

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  25. Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers

    Article • Journal of Physiology and Biochemistry, June 2015, Springer Science + Business Media

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  26. The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood–Retinal Barrier Breakdown

    Article • Investigative Ophthalmology & Visual Science, March 2015, Association for Research in Vision and Ophthalmology (ARVO)

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  27. The Tumor Necrosis Factor Superfamily Members TWEAK, TNFSF15 and Fibroblast Growth Factor-Inducible Protein 14 Are Upregulated in Proliferative Diabetic Retinopathy

    Article • Ophthalmic Research, January 2015, Karger Publishers

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  28. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina

    Article • Current Eye Research, December 2014, Taylor & Francis

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  29. Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy

    Article • Lipids in Health and Disease, December 2014, Springer Science + Business Media

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  30. Functional links between gelatinase B/matrix metalloproteinase-9 and prominin-1/CD133 in diabetic retinal vasculopathy and neuropathy

    Article • Progress in Retinal and Eye Research, November 2014, Elsevier

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  31. The Proinflammatory Cytokine High-Mobility Group Box-1 Mediates Retinal Neuropathy Induced by Diabetes

    Article • Mediators of Inflammation, January 2014, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  32. Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy

    Article • PLOS One, December 2013, PLOS

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  33. Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy

    Article • PLOS One, June 2013, PLOS

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  34. High-Mobility Group Box-1 Induces Decreased Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in the Diabetic Retina

    Article • Mediators of Inflammation, January 2013, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  35. Poly (ADP-Ribose) Polymerase Mediates Diabetes-Induced Retinal Neuropathy

    Article • Mediators of Inflammation, January 2013, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  36. Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy

    Article • Journal of Diabetes Research, January 2013, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  37. Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy

    Article • Acta Diabetologica, August 2012, Springer Science + Business Media

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  38. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy

    Article • Journal of Diabetes and its Complications, January 2012, Elsevier

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  39. Osteopontin and Other Regulators of Angiogenesis and Fibrogenesis in the Vitreous from Patients with Proliferative Vitreoretinal Disorders

    Article • Mediators of Inflammation, January 2012, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  40. Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy

    Article • Acta Diabetologica, September 2011, Springer Science + Business Media

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  41. Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnormalities in rats

    Article • Behavioural Pharmacology, July 2009, Wolters Kluwer Health

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  42. Protective Effect of Hydrocortisone on Iminodipropionitrile‐Induced Neurotoxicity in Rats

    Article • Basic & Clinical Pharmacology & Toxicology, January 2007, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI

  43. Patterns of prescription and drug use in ophthalmology in a tertiary hospital in Delhi

    Article • British Journal of Clinical Pharmacology, March 2001, Wiley

    Mr MOHAMMAD MAIRAJ SIDDIQUEI